SCHEMBL5458347

SCHEMBL5458347

COc1ccccc1NC(=O)Nc1ccc(C2CCNCC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.61
MAPT P10636 6/20 0.61
NPC1 O15118 5/20 0.61
SMN1; SMN2 Q16637 4/20 0.61
JAK3 P52333 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.57
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 1/20 0.53
THRB P10828 1/20 0.53
NAMPT P43490 1/20 0.52
TP53 P04637 1/20 0.52
PKM P14618 1/20 0.52
LMNA P02545 1/20 0.52
POLB P06746 1/20 0.51
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5462493 0.85 KMT2A (0.63) RAB9AMAPTSMN1; SMN2JAK3CA12
SCHEMBL3307712 0.85 RAB9A (0.60) RAB9AMAPTNPC1SMN1; SMN2L3MBTL1
SCHEMBL3307714 0.85 RAB9A (0.60) RAB9AMAPTNPC1SMN1; SMN2L3MBTL1
SCHEMBL5458362 0.83 RAB9A (0.58) RAB9AMAPTNPC1SMN1; SMN2L3MBTL1
SCHEMBL5460945 0.81 JAK3 (0.62) RAB9AMAPTNPC1SMN1; SMN2JAK3
SCHEMBL5466574 0.81 JAK3 (0.55) RAB9ANPC1SMN1; SMN2JAK3NAMPT
SCHEMBL5460083 0.79 RAB9A (0.77) RAB9AMAPTNPC1SMN1; SMN2L3MBTL1
SCHEMBL5456870 0.79 NAMPT (0.64) RAB9AMAPTNPC1SMN1; SMN2JAK3
SCHEMBL11006683 0.76 RAB9A (0.78) RAB9AMAPTNPC1SMN1; SMN2L3MBTL1
SCHEMBL5852135 0.76 MAPT (0.78) RAB9AMAPTNPC1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 RAB9A 1528/4885MAPT 758/4885NPC1 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.